Blockade by antiglucocorticoids, actinomycin D and cycloheximide of anti-inflammatory action of dexamethasone against bradykinin.
D000735:Androstenedione / Q000494:pharmacology*; D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D001920:Bradykinin / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D002463:Cell Membrane Permeability; D003513:Cycloheximide / Q000494:pharmacology*; D003609:Dactinomycin / Q000494:pharmacology*; D003907:Dexamethasone / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D005938:Glucocorticoids / Q000037:antagonists & inhibitors / Q000494:pharmacology; D007249:Inflammation / Q000188:drug therapy*; D008297:Male; D008777:Methyltestosterone / Q000494:pharmacology*; D051379:Mice; D010653:Phenylbutazone / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology*; D011453:Prostaglandins / Q000096:biosynthesis; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D013997:Time Factors
D005938:Glucocorticoids; D011453:Prostaglandins; D003609:Dactinomycin; D000735:Androstenedione; D011374:Progesterone; D012313:RNA; D003907:Dexamethasone; D003513:Cycloheximide; D010653:Phenylbutazone; D001241:Aspirin; D001920:Bradykinin; D008777:Methyltestosterone